RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022)
RedHill Biopharma (RDHL) FCF Margin Growth (1y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -209.00 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 301.00 |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1,940.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4,839.00 |
| Sep 30, 2022 | 5,373.00 |
| Jun 30, 2022 | -162.00 |
| Mar 31, 2022 | 2,758.00 |
| Dec 31, 2021 | -834.00 |
| Sep 30, 2021 | -4,495.00 |
| Jun 30, 2021 | -1,606.00 |
| Mar 31, 2021 | 92,395.00 |
| Dec 31, 2020 | 81,122.00 |
| Sep 30, 2020 | 59,176.00 |
| Jun 30, 2020 | 58,877.00 |
| Mar 31, 2020 | -54,981.00 |
| Dec 31, 2019 | -26,761.00 |
| Sep 30, 2019 | -25,539.00 |
| Jun 30, 2019 | -30,327.00 |
| Mar 31, 2019 | -4,548.00 |
| Dec 31, 2018 | 10,522.00 |
| Sep 30, 2018 | 31,097.00 |
| Jun 30, 2018 | 163,564.00 |
| Mar 31, 2018 | -20.68 Mn |